Why Did Ken Griffin Buy Sweetgreen Stock?
In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…
Buy
67
GDOC Quote, Financials, Valuation and Earnings
Last price:
$31.52
Seasonality move
:
2.81%
Day range:
$31.80 - $31.88
52-week range:
$28.34 - $37.23
Dividend yield:
0.02%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.2K
Avg. volume:
1.3K
1-year change:
-8.43%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
$31.80 | -- | -- | -- | $0.01 | 0.02% | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
$24.10 | -- | -- | -- | $0.11 | 0.47% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$24.84 | -- | -- | -- | $0.12 | 1.93% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$28.77 | -- | -- | -- | $0.47 | 0.5% | -- |
|
MEDI
Harbor Health Care ETF
|
$26.55 | -- | -- | -- | $0.13 | 0.37% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | 0.794 | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | 0.969 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 0.835 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 0.636 | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | 0.780 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- | -- |
Goldman Sachs Future Health Care Equity ETF vs. Competitors
-
Which has Higher Returns GDOC or FMED?
Fidelity Disruptive Medicine ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Fidelity Disruptive Medicine ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- -
What do Analysts Say About GDOC or FMED?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity Disruptive Medicine ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Fidelity Disruptive Medicine ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Fidelity Disruptive Medicine ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 FMEDFidelity Disruptive Medicine ETF0 0 0 -
Is GDOC or FMED More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Fidelity Disruptive Medicine ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or FMED?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.02%. Fidelity Disruptive Medicine ETF offers a yield of 0.47% to investors and pays a quarterly dividend of $0.11 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Fidelity Disruptive Medicine ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or FMED?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Fidelity Disruptive Medicine ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Fidelity Disruptive Medicine ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Fidelity Disruptive Medicine ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Fidelity Disruptive Medicine ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- --
-
Which has Higher Returns GDOC or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About GDOC or FTXH?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is GDOC or FTXH More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.659, suggesting its less volatile than the S&P 500 by 34.143%.
-
Which is a Better Dividend Stock GDOC or FTXH?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.02%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.93% to investors and pays a quarterly dividend of $0.12 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or FTXH?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns GDOC or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About GDOC or HRTS?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is GDOC or HRTS More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or HRTS?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.02%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.5% to investors and pays a quarterly dividend of $0.47 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or HRTS?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns GDOC or MEDI?
Harbor Health Care ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Harbor Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- MEDIHarbor Health Care ETF-- -- -- -
What do Analysts Say About GDOC or MEDI?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Harbor Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Harbor Health Care ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Harbor Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 MEDIHarbor Health Care ETF0 0 0 -
Is GDOC or MEDI More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Harbor Health Care ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or MEDI?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.02%. Harbor Health Care ETF offers a yield of 0.37% to investors and pays a quarterly dividend of $0.13 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Harbor Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or MEDI?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Harbor Health Care ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Harbor Health Care ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Harbor Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Harbor Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- MEDIHarbor Health Care ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Planet Labs’ Stock Go Next?
On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…
Where Will VICI Properties Be in 5 Years?
VICI Properties (NYSE:VICI) is a real estate investment trust focused…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
73
OKLO alert for Jun 12
Oklo [OKLO] is down 5.6% over the past day.
Buy
87
SMR alert for Jun 12
NuScale Power [SMR] is down 2.96% over the past day.
Buy
53
PLAY alert for Jun 12
Dave & Buster's Entertainment [PLAY] is up 0.69% over the past day.
